Back to Trades
Espinoza Octavio
Chief Financial OfficerCIK 0001905248
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 13
- Companies
- 1
- Active
- 2025–2026
Espinoza Octavio, Chief Financial Officer, has filed 9 reports across 1 company, totaling $12.3M in disclosed volume. Sales ($3.8M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| May 28 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $0 |
| Mar 27 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Grant | $0 |
| Mar 13 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $687.8K |
| Mar 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $2.8M |
| Feb 18 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Grant | $0 |
| Jan 6 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $0 |
| Dec 18 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $0 |
| Dec 16 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Sell | $339.7K |
| Dec 9 | LGND LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Other | $0 |
9 filings